ILLUMINA, INC.
Company Information
Industry
Laboratory Analytical Instruments
SIC Code
3826
Entity Type
operating
SEC Category
Large accelerated filer
State of Incorporation
DE
Business Address
5200 ILLUMINA WAY, SAN DIEGO, CA, 92122
Mailing Address
5200 ILLUMINA WAY, SAN DIEGO, CA, 92122
Phone
8582024500
Fiscal Year End
0103
EIN
330804655
Financial Overview
FY2025
$6.64B
Total Assets
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | April 2, 2026 | View on SEC |
| 8-K Current report of material events | April 2, 2026 | View on SEC |
| 4 Insider stock transaction report | April 2, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | March 27, 2026 | View on SEC |
| 4 Insider stock transaction report | March 9, 2026 | View on SEC |
| 4 Insider stock transaction report | March 9, 2026 | View on SEC |
| 4 Insider stock transaction report | March 9, 2026 | View on SEC |
| 4 Insider stock transaction report | March 9, 2026 | View on SEC |
| 4 Insider stock transaction report | March 9, 2026 | View on SEC |
| 4 Insider stock transaction report | March 9, 2026 | View on SEC |
Annual Reports
10-K
February 12, 2026
- Leads the global genomics market with advanced sequencing technology and a broad installed base.
- Successfully divested GRAIL, refocusing on its core genomics business and reducing regulatory uncertainty.
Material Events
8-K
Acquisition
January 30, 2026
High Impact
- Illumina enters the rapidly expanding proteomics market with a strategic acquisition.
- Positions Illumina as a leader in 'multi-omics' by integrating genomics and proteomics.
Insider Trading
STRONG SELL
4 insiders
5 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 3826)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.